bradley mcgregor, md, discusses checkmate-214 investigating nivolumab ipilimumab in rcc patients
Published 4 years ago • 99 plays • Length 1:49
Download video MP4
Download video MP3
Similar videos
-
2:45
david quinn, md, discusses checkmate-214 investigating nivolumab ipilimumab in arcc patients
-
2:01
michael atkins, md, discusses checkmate-214 investigating nivolumab ipilimumab in rcc patients
-
1:29
bradley mcgregor, md, on combo ipilimumab nivolumab in variant histologies of bladder cancer
-
5:10
checkmate 214: patterns of progression with nivolumab plus ipilimumab versus sunitinib for rcc
-
1:56
nivolumab and ipilimumab for advanced bcvh
-
0:47
eric jonasch, md, on the 4 year checkmate-214 follow up investigating nivolumab ipilimumab
-
1:01
bradley mcgregor, md, describes if biomarkers help guide treatment in advanced renal cell carcinoma
-
1:13
bradley mcgregor, md, on mrcc patients whose cancer returns and were previously treated with i-o
-
1:18
bradley mcgregor, md, considers strategies for treating 2nd line rcc patients
-
1:19
bradley mcgregor, md, on impressions of the oral inhibitor study in renal cell carcinoma patients
-
1:32
bradley mcgregor, md, shares presented data investigating atezolizumab and cabozantinib in mcrpc
-
2:09
bradley mcgregor, md, considers the optimal approach to treating newly diagnosed rcc patients
-
3:07
checkmate-214: nivolumab/ipilimumab for mrcc?
-
1:16
dr. mcgregor on combination therapies with nivolumab, cabozantinib, and sunitinib in rcc
-
1:08
dr. motzer on nivolumab/ipilimumab activity in rcc
-
1:02
current status of vegf inhibitor/immunotherapy combinations in rcc
-
5:06
phase 3 checkmate - 214
-
1:33
checkmate 920: nivolumab plus ipilimumab for renal cell cancer
-
4:13
checkmate 214: nivolumab ipilimumab vs sunitinib for advanced or metastatic renal cell carcinoma
Clip.africa.com - Privacy-policy